Logos Global Management’s Design Therapeutics DSGN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$20.7M	Sell	1,950,000 -550,000	-22%	-$5.57M	1.07%	32
2025 Q4	$23.4M	Sell	2,500,000 -1,155,000	-32%	-$9.04M	1.56%	25
2025 Q3	$27.5M	Sell	3,655,000 -562,627	-13%	-$2.82M	2.72%	16
2025 Q2	$14.2M	Hold	4,217,627	–	–	1.9%	22
2025 Q1	$16.3M	Hold	4,217,627	–	–	2.89%	15
2024 Q4	$26M	Hold	4,217,627	–	–	3.04%	12
2024 Q3	$22.7M	Sell	4,217,627 -814,874	-16%	-$3.83M	2.54%	17
2024 Q2	$16.9M	Hold	5,032,501	–	–	1.94%	20
2024 Q1	$20.3M	Hold	5,032,501	–	–	2.13%	20
2023 Q4	$13.3M	Hold	5,032,501	–	–	1.48%	21
2023 Q3	$11.9M	Buy	5,032,501 +2,235,000	+80%	+$10.4M	1.69%	24
2023 Q2	$17.6M	Hold	2,797,501	–	–	2.43%	15
2023 Q1	$16.1M	Hold	2,797,501	–	–	2.31%	15
2022 Q4	$28.7M	Hold	2,797,501	–	–	3.36%	11
2022 Q3	$46.8M	Hold	2,797,501	–	–	5.77%	5
2022 Q2	$39.2M	Hold	2,797,501	–	–	7.19%	4
2022 Q1	$45.2M	Buy	2,797,501 +25,000	+0.9%	+$383K	5.86%	4
2021 Q4	$59.4M	Hold	2,772,501	–	–	6.12%	3
2021 Q3	$40.7M	Buy	2,772,501 +40,000	+1%	+$665K	2.94%	12
2021 Q2	$54.3M	Hold	2,732,501	–	–	4.66%	3
2021 Q1	$81.7M	Buy	+2,732,501	New	+$92.2M	7.97%	3

Other funds holding DSGN